51. 全身性強皮症 Scleroderma Clinical trials / Disease details

臨床試験数 : 525 / 薬物数 : 565 - (DrugBank : 148) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 217

5 trials found

diseases per page:

Showing 1 to 5 of 5 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ITMCTR2100004289	2021-03-01	2021-01-19	Observation of curative effection of Milli Fire Needle in treating Localized Scleroderma	Feasibility and Safety of Milli Fire Needle in Localized Scleroderma Treatment	Localized Scleroderma	control group:0.1% tacrolimus oinment;treatment group:Milli Fire Needle+0.1% tacrolimus oinment;	The First Affiliated Hospital of Guangzhou University of Chinese Medicine	NULL	Recruiting	18	65	Both	control group:45;treatment group:45;		China
2	ChiCTR2100042327	2021-03-01	2021-01-19	Observation of curative effection of Milli Fire Needle in treating Localized Scleroderma	Feasibility and Safety of Milli Fire Needle in Localized Scleroderma Treatment	Localized Scleroderma	treatment group:Milli Fire Needle+0.1% tacrolimus oinment;control group:0.1% tacrolimus oinment;	The First Affiliated Hospital of Guangzhou University of Chinese Medicine	NULL	Recruiting	18	65	Both	treatment group:45;control group:45;		China
3	NCT02680717 (ClinicalTrials.gov)	March 2016	9/2/2016	Comparative Effectiveness Trial in the Treatment of Pediatric Plaque Morphea	Comparative Effectiveness Trial of Topical Calcipotriene, Clobetasol, and Tacrolimusin the Treatment ...	Scleroderma	Drug: Clobetasol;Drug: Calcipotriene;Drug: Tacrolimus	Medical College of Wisconsin	Mayo Clinic;Seattle Children's Hospital;University of Toronto	Withdrawn	2 Years	18 Years	All	0	Phase 1	NULL
4	NCT01047072 (ClinicalTrials.gov)	January 2010	11/1/2010	Low-Dose Conditioning Followed by Donor Stem Cell Transplant in Treating Patients With Severe System ...	Phase II Clinical Trial of Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Cond ...	Systemic Scleroderma	Drug: fludarabine phosphate;Radiation: total-body irradiation;Drug: tacrolimus;Drug: mycophenolate mof ...	Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium	National Cancer Institute (NCI)	Withdrawn	18 Years	65 Years	Both	0	Phase 2	United States
5	NCT00622895 (ClinicalTrials.gov)	September 1, 2006	22/2/2008	Allogeneic Hematopoietic Cell Transplantation for Severe Systemic Sclerosis	Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning for Patients With ...	Systemic Scleroderma;Severe Systemic Sclerosis	Drug: fludarabine phosphate;Drug: Mycophenolic Acid;Drug: tacrolimus;Radiation: total-body irradiatio ...	Fred Hutchinson Cancer Research Center	National Institute of Allergy and Infectious Diseases (NIAID)	Completed	N/A	70 Years	All	3	Phase 1/Phase 2	United States

First Previous1Next Last